|
Atomistry » Magnesium » PDB 6mxd-6n6n » 6n2j | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Magnesium » PDB 6mxd-6n6n » 6n2j » |
Magnesium in PDB 6n2j: Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12CProtein crystallography data
The structure of Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C, PDB code: 6n2j
was solved by
G.P.Vigers,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C
(pdb code 6n2j). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C, PDB code: 6n2j: Magnesium binding site 1 out of 1 in 6n2jGo back to Magnesium Binding Sites List in 6n2j
Magnesium binding site 1 out
of 1 in the Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C
Mono view Stereo pair view
Reference:
J.B.Fell,
J.P.Fischer,
B.R.Baer,
J.Ballard,
J.F.Blake,
K.Bouhana,
B.J.Brandhuber,
D.M.Briere,
L.E.Burgess,
M.R.Burkard,
H.Chiang,
M.J.Chicarelli,
K.Davidson,
J.J.Gaudino,
J.Hallin,
L.Hanson,
K.Hee,
E.J.Hicken,
R.J.Hinklin,
M.A.Marx,
M.J.Mejia,
P.Olson,
P.Savechenkov,
N.Sudhakar,
T.P.Tang,
G.P.Vigers,
H.Zecca,
J.G.Christensen.
Discovery of Tetrahydropyridopyrimidines As Irreversible Covalent Inhibitors of Kras-G12C with in Vivo Activity. Acs Med Chem Lett V. 9 1230 2018.
Page generated: Tue Oct 1 12:23:52 2024
ISSN: ISSN 1948-5875 PubMed: 30613331 DOI: 10.1021/ACSMEDCHEMLETT.8B00382 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |